I think it's most likely your #2, don't forget they have a licensee with skin in the game for this indication, and that licensee will have their own thoughts on whether to halt the trial or continue it, strategy on approaching FDA, etc. They would need time to discuss with Novartis.
Better too, to halt immediately and stop any further deterioration in share price, which impacts the amount of equity Novartis gets for its $25 million.
- Forums
- ASX - By Stock
- MSB
- Ann: Trading halt
Ann: Trading halt, page-154
-
- There are more pages in this discussion • 643 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.018(1.50%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.183M | 1.011M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 64675 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 37319 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 200252 | 1.185 |
13 | 40944 | 1.180 |
11 | 106494 | 1.175 |
11 | 136676 | 1.170 |
6 | 55721 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 41020 | 2 |
1.195 | 66345 | 11 |
1.200 | 144652 | 17 |
1.205 | 106279 | 10 |
1.210 | 122829 | 9 |
Last trade - 10.55am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online